Fmr1 deletion enhances and ultimately desensitizes CB1 signaling in autaptic hippocampal neurons

Neurobiology of Disease

Volumn 56, Issue , 2013, Pages 1-5

  Straiker, Alex ^a   Min, Kyung Tai ^b   Mackie, Ken ^a  

^a INDIANA UNIVERSITY   (United States)

^b Ulsan National Institute of Science and Technology   (South Korea)

Author keywords

Cannabinoid; CB1; Fmr1; Fragile X; MGluR

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GLUTAMIC ACID; METABOTROPIC RECEPTOR;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL CULTURE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DEPOLARIZATION INDUCED SUPPRESSION OF EXCITATION; FMR1 GENE; GENE; GENE DELETION; HIPPOCAMPUS; KNOCKOUT MOUSE; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOSINE; ANIMALS; BACLOFEN; DATA INTERPRETATION, STATISTICAL; ELECTROPHYSIOLOGICAL PROCESSES; EXCITATORY POSTSYNAPTIC POTENTIALS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GABA AGONISTS; HIPPOCAMPUS; METHOXYHYDROXYPHENYLGLYCOL; MICE; MICE, KNOCKOUT; NEURONS; RECEPTOR, CANNABINOID, CB1; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPSES;

EID: 84877012162     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.04.002     Document Type: Article

References (34)

1. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004, 27(7):370-377.
2. Bear M.F., Dolen G., Osterweil E., Nagarajan N. Fragile X: translation in action. Neuropsychopharmacology 2008, 33(1):84-87.
3. Bekkers J.M., Stevens C.F. Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proc. Natl. Acad. Sci. U. S. A. 1991, 88(17):7834-7838.
4. Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 2003, 163(3):463-468.
5. Brenowitz S.D., Regehr W.G. Calcium dependence of retrograde inhibition by endocannabinoids at synapses onto Purkinje cells. J. Neurosci. 2003, 23(15):6373-6384.
6. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(16):10819-10824.
7. Dolen G., Osterweil E., Rao B.S., Smith G.B., Auerbach B.D., Chattarji S., et al. Correction of fragile X syndrome in mice. Neuron 2007, 56(6):955-962.
8. Furshpan E.J., MacLeish P.R., O'Lague P.H., Potter D.D. Chemical transmission between rat sympathetic neurons and cardiac myocytes developing in microcultures: evidence for cholinergic, adrenergic, and dual-function neurons. Proc. Natl. Acad. Sci. U. S. A. 1976, 73(11):4225-4229.
9. Gao Y., Vasilyev D.V., Goncalves M.B., Howell F.V., Hobbs C., Reisenberg M., et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci. 2010, 30(6):2017-2024.
10. Gaoni Y., Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 1964, 86:1646-1647.
11. Hashimotodani Y., Ohno-Shosaku T., Tsubokawa H., Ogata H., Emoto K., Maejima T., et al. Phospholipase Cbeta serves as a coincidence detector through its Ca(2+) dependency for triggering retrograde endocannabinoid signal. Neuron 2005, 45(2):257-268.
12. Hashimotodani Y., Ohno-Shosaku T., Kano M. Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities. Curr. Opin. Neurobiol. 2007, 17(3):6.
13. Hashimotodani Y., Ohno-Shosaku T., Maejima T., Fukami K., Kano M. Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocannabinoid release. Neuropharmacology 2008, 54(1):58-67.
14. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., et al. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U. S. A. 1990, 87(5):1932-1936.
15. Huber K.M., Gallagher S.M., Warren S.T., Bear M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(11):7746-7750.
16. Jung K.M., Sepers M., Henstridge C.M., Lassalle O., Neuhofer D., Martin H., et al. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat. Commun. 2012, 3:1080.
17. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 2009, 89(1):309-380.
18. Kerbeshian J., Burd L., Martsolf J. A family with fragile-X syndrome. J. Nerv. Ment. Dis. 1984, 172(9):549-551.
19. Kreitzer A.C., Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 2001, 29(3):717-727.
20. Levison S.W., McCarthy K.D. Characterization and partial purification of AIM: a plasma protein that induces rat cerebral type 2 astroglia from bipotential glial progenitors. J. Neurochem. 1991, 57(3):782-794.
21. Lutz B. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem. Pharmacol. 2004, 68(9):1691-1698.
22. Maejima T., Hashimoto K., Yoshida T., Aiba A., Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 2001, 31(3):463-475.
23. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346(6284):561-564.
24. Ohno-Shosaku T., Tsubokawa H., Mizushima I., Yoneda N., Zimmer A., Kano M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci. 2002, 22(10):3864-3872.
25. Pfeiffer B.E., Huber K.M. Current advances in local protein synthesis and synaptic plasticity. J. Neurosci. 2006, 26(27):7147-7150.
26. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388(6644):773-778.
27. Straiker A., Mackie K. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J. Physiol. 2005, 569(Pt 2):501-517.
28. Straiker A., Mackie K. Metabotropic suppression of excitation in murine autaptic hippocampal neurons. J. Physiol. 2007, 578(Pt 3):773-785.
29. Straiker A., Mackie K. Cannabinoid signaling in inhibitory autaptic hippocampal neurons. Neuroscience 2009, 163(1):11.
30. Straiker A., Hu S.S., Long J.Z., Arnold A., Wager-Miller J., Cravatt B.F., et al. Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol. Pharmacol. 2009, 76(6):1220-1227.
31. Straiker A., Wager-Miller J., Hutchens J., Mackie K. Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones. Br. J. Pharmacol. 2012, 165(8):2660-2671.
32. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991, 65(5):905-914.
33. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410(6828):588-592.
34. Zhang L., Alger B.E. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J. Neurosci. 2010, 30(16):5724-5729.